Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis

International Archives of Allergy and Immunology

Volumn 166, Issue 3, 2015, Pages 177-188

  Okamoto, Yoshitaka ^a   Okubo, Kimihiro ^e   Yonekura, Syuji ^a   Hashiguchi, Kazuhiro ^f   Goto, Minoru ^g   Otsuka, Takashi ^m   Murata, Tadayuki ⁱ   Nakao, Yuji ^j   Kanazawa, Chigiri ^k   Nagakura, Hitoshi ^h   Okawa, Toru ^b   Nakano, Koichi ^c   Hisamitsu, Minako ^d   Kaneko, Shinya ^l   Konno, Akiyoshi ⁿ  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Okawa ENT Clinic   (Japan)

^c Nakano Internal Medicine Clinic   (Japan)

^d Chiba Kaihin Municipal Hospital   (Japan)

^e NIPPON MEDICAL SCHOOL   (Japan)

^f Futaba Clinic   (Japan)

^g NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

^h Endo Ear Nose Throat and Allergy Clinic   (Japan)

ⁱ Morishita Otolaryngology Clinic   (Japan)

^j Ogikubo Nakao ENT Clinic   (Japan)

^k Kanazawa Clinic of Ear Nose Throat   (Japan)

^l Torii Nihonbashi Building   (Japan)

^m Department of Nephrology   (Japan)

ⁿ Southern Tohoku General Hospital   (Japan)

more..

Author keywords

Japanese cedar pollinosis; Pollen extract; Seasonal allergic rhinitis; Sublingual immunotherapy

Indexed keywords

ANTIALLERGIC AGENT; FEXOFENADINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; JAPANESE CEDAR POLLEN EXTRACT; KETOTIFEN; POLLEN EXTRACT; TRAMAZOLINE; UNCLASSIFIED DRUG; IMMUNOGLOBULIN G; PLACEBO; PLANT EXTRACT;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE DURATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; EAR PRURITUS; EPIPHORA; FAMILY HISTORY; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; JAPANESE CEDAR; JAPANESE CEDAR POLLINOSIS; MAJOR CLINICAL STUDY; MALE; MOUTH EDEMA; MULTICENTER STUDY; NOSE OBSTRUCTION; OCULAR PRURITUS; ORAL PRURITUS; PHASE 3 CLINICAL TRIAL; POLLEN ALLERGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINORRHEA; SEASON; SNEEZING; STOMATITIS; SUBLINGUAL IMMUNOTHERAPY; SYMPTOM ASSESSMENT; THROAT IRRITATION; TOTAL NASAL SYMPTOM AND MEDICATION SCORE; TOTAL OCULAR SYMPTOM AND MEDICATION SCORE; ADVERSE EFFECTS; BLOOD; CLINICAL TRIAL; DESENSITIZATION; IMMUNOLOGY; JAPAN; METABOLISM; MIDDLE AGED; POLLEN; PROCEDURES; RHINITIS, ALLERGIC, SEASONAL; SUBLINGUAL DRUG ADMINISTRATION; YOUNG ADULT;

ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; CHILD; CRYPTOMERIA; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; JAPAN; MALE; MIDDLE AGED; PLACEBOS; PLANT EXTRACTS; POLLEN; RHINITIS, ALLERGIC, SEASONAL; SUBLINGUAL IMMUNOTHERAPY; YOUNG ADULT;

EID: 84928162340     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000381059     Document Type: Article

References (26)

1. Okamoto Y, Horiguchi S. Yonekura S, Yamamoto H, Hanazawa T: Present situation of cedar pollinosis in Japan and its immune responses. Allergol Int 2009; 58: 152-162.
2. Okuda M: Epidemiology of Japanese cedar pollinosis throughout Japan. Ann Allergy Asthma Immunol 2003; 91: 288-296.
3. Ozasa K, Dejima K, Takenaka H: Prevalence of Japanese cedar pollinosis in Japanese school children. Int Arch Allergy Immunol 2002; 128: 165-167.
4. Sakashita M, Hirota T, Harada M, Nakamichi R, Tsunoda T, Osawa Y, Kojima A, Okamoto M, Suzuki D, Kubo S, Imoto Y, Nakamura Y, Tamari M, Fujieda S: Prevalence of allergic rhinitis and sensitization to common aeroallergens in a Japanese population. Int Arch Allergy Immunol 2010; 151: 255-261.
5. Yonekura S, Okamoto Y, Horiguchi S, Sakurai D, Chazono H, Hanazawa T, Aoki S, Konno A: Effect of aging on the natural history of seasonal allergic rhinitis in middleaged subjects in south Chiba, Japan. Int Arch Allergy Immunol 2012; 157: 73-80.
6. Fujieda S, Kurono Y, Okubo K, Ichimura K, Enomoto T, Kawauchi H, Masuyama K, Goto M, Suzuki H, Okamoto Y, Takenaka H: Examination, diagnosis and classification for allergic rhinitis: Japanese guideline. Auris Nasus Larynx 2012; 39: 553-556.
7. Bernstein DI, Wanner M, Borish L, Liss GM; Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology: Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol 2004; 113: 1129-1136.
8. Durham SR, Emminger W, Kapp A, de Monchy JG, Rak S, Scadding GK, Wurtzen PA, Andersen JS, Tholstrup B, Riis B, Dahl R: SQstandardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012; 129: 717-725.
9. Didier A, Worm M, Horak F, Sussman G, de Beaumont O, Le Gall M, Melac M, Malling HJ: Sustained 3-year efficacy of pre-and coseasonal 5-grass-pollen sublingual immunotherapy tablets in patients with grass pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol 2011; 128: 559-566.
10. Nelson HS, Nolte H, Creticos P, Maloney J, Wu J, Bernstein DI: Efficacy and safety of Timothy grass allergy immunotherapy tablet treatment in North American adults. J Allergy Clin Immunol 2011; 127: 72-80.
11. Cox LS, Casale TB, Nayak AS, Bernstein DI, Creticos PS, Ambroisine L, Melac M, Zeldin RK: Clinical efficacy of 300IR 5-grass pollen sublingual tablet in US study. J Allergy Clin Immunol 2012; 130: 1327-1334.
12. Horiguchi S, Okamoto Y, Yonekura S, Okawa T, Yamamoto H, Kunii N, Sakurai D, Fujimura T, Nakazawa K, Yasueda H: A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis. Int Arch Allergy Immunol 2008; 146: 76-84.
13. Okubo K, Gotoh M, Fujieda S, Okano M, Yoshida H, Morikawa H, Masuyama K, Okamoto Y, Kobayashi M: A randomised doubleblind comparative study of sublingual immunotherapy for cedar pollinosis. Allergol Int 2008; 57: 265-275.
14. Fujimura T, Yonekura S, Horiguchi S, Taniguchi Y, Saito, A, Yasueda H, Inamine A, Nakayama T, Takemori T, Taniguchi M, Sakaguchi M, Okamoto Y: Increase of regulatory T cells and the ratio of specific IgE to total IgE are candidates for response monitoring or prognostic biomarkers in two-year sublingual immunotherapy (SLIT) for Japanese cedar pollinosis. Clin Immunol 2011; 139: 65-74.
15. Durham OC: The volumetric incidence of atmospheric allergens; a proposed standard method of gravity sampling, counting, and volumetric interpolation of results. J Allergy 1946; 17: 79-86.
16. Okuda M, Ohkubo K, Goto M, Okamoto H, Konno A, Baba K, Ogino S, Enomoto M, Imai T, So N, Ishikawa Y, Takenaka Y, Manndai T, Crawford B: Comparative study of two Japanese rhinoconjunctivitis quality-of-life questionnaires. Acta Otolaryngol 2005; 125: 736-744.
17. Okuda M, Okubo K, Gotoh M, Okamoto Y, Imano A, Baba K, Ogino T, Ishikawa K, Takenata Y, So N, Imai T, Enomoto M, Mandai T, Crawford B: Standard questionnaire for QOL of Japanese patients with allergic rhinitis. Arerugi 2003; 52(suppl 1):21-56.
18. Sasaki K, Okamoto Y, Yonekura S, Okawa T, Horiguchi S, Chazono H, Hisamitsu M, Sakurai D, Hanazawa T, Okubo K: Cedar and cypress pollinosis and allergic rhinitis: quality of life effects of early intervention with leukotriene receptor antagonists. Int Arch Allergy Immunol 2009; 149: 350-358.
19. Dahl R, Kapp A, Colombo G, de Monchy JG, Rak S, Emminger W, Rivas MF, Ribel M, Durham SR: Efficacy and safety of sublingual immunotherapy with grass allergen tablets for seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol 2006; 118: 434-440.
20. Pajno GB, Caminiti L, Crisafulli G, Vita D, Valenzise M, De Luca R, Passalacqua G: Direct comparison between continuous and coseasonal regimen for sublingual immunotherapy in children with grass allergy: a randomized controlled study. Pediatr Allergy Immunol 2011; 22: 803-807.
21. Stelmach I, Kaluzinska-Parzyszek I, Jerzynska J, Stelmach P, Stelmach W, Majak P: Comparative effect of pre-coseasonal and continuous grass sublingual immunotherapy in children. Allergy 2012; 67: 312-320.
22. Didier A, Malling HJ, Worm M, Horak F, Jäger S, Montagut A, André C, de Beaumont O, Melac M: Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol 2007; 120: 1338-1345.
23. Di Lorenzo G, Mansueto P, Oacor ML, Rizzo M, Castello F, Martinelli N, Ditta V, Lo Bianco C, Leto-Barone MS, D'Alcamo A, Di Fede G, Rini GB, Ditto AM: Evaluation of serum s-IgE/total IgE ratio in predicting clinical responses to allergen-specific immunotherapy. J Allerg Clin Immunol 2009; 123: 1103-1110.
24. Canonica GW, Bousquet J, Casale T, Lockey RF, Baena-Cagnani CE, Pawanker R, et al: Sub-lingual immunotherapy: World Allergy Organization position paper 2009. World Allergy Organ J 2009; 2: 233-281.
25. Bousquet J, Lockey R, Malling HJ: Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 1998; 102: 558-562.
26. Durham SR, Emminger W, Kapp A, de Monchy JG, Rak S, Scadding GK, Wurtzen PA, Andersen JS, Tholstrup B, Riis B, Dahl R: SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol 2012; 129: 717-725.